-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q2 2024.
- Elicio Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $10.9M, a 40.5% increase year-over-year.
- Elicio Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $41.3M, a 144% increase year-over-year.
- Elicio Therapeutics, Inc. annual Costs and Expenses for 2023 was $35.7M, a 50.6% increase from 2022.
- Elicio Therapeutics, Inc. annual Costs and Expenses for 2022 was $23.7M, a 64.9% decline from 2021.
- Elicio Therapeutics, Inc. annual Costs and Expenses for 2021 was $67.6M, a 16.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)